Turning Point Therapeutics, Inc.
TPTX · NASDAQ
6/30/2022 | 3/31/2022 | 12/31/2021 | 9/30/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$123,088 | -$74,445 | -$78,449 | -$66,325 |
| Dep. & Amort. | $1,316 | $1,254 | $1,274 | $1,210 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $17,311 | $15,089 | $14,190 | $13,794 |
| Change in WC | -$1,367 | -$1,122 | $7,594 | $8,334 |
| Other Non-Cash | $530 | $893 | $1,240 | $1,322 |
| Operating Cash Flow | -$105,298 | -$58,331 | -$54,151 | -$41,665 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,527 | -$447 | -$387 | -$1,166 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$29,754 | -$134,783 | -$47,886 | -$135,581 |
| Inv. Sales/Matur. | $108,220 | $74,818 | $123,495 | $154,190 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $76,939 | -$60,412 | $75,222 | $17,443 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $9,370 | $396 | $14,325 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$396 | $396 | $2,605 | $2,379 |
| Financing Cash Flow | $8,974 | $396 | $2,605 | $2,379 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$19,385 | -$118,347 | $23,676 | -$21,843 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $311,408 | $429,755 | $406,079 | $427,922 |
| End Cash | $292,023 | $311,408 | $429,755 | $406,079 |
| Free Cash Flow | -$106,825 | -$58,778 | -$54,538 | -$42,831 |